I. Introduction
===============

Psychologic, social, and biologic factors are several causes of temporomandibular joint dysfunction (TMJD). The relief of pain and the ability to masticate are considered the principal concerns for patients. An understanding of the psychological conditions with proper treatments for chronic pain and dysfunction must be considered^[@ref1]^. The ultimate success was achieved when the operator met the patients' expectations by improving their quality of life^[@ref2]^.

Successful treatment of TMJD depends on an accurate diagnosis followed by the selection of proper treatment. Treatment modalities applied to relieve pain and other symptoms of this disorder are classified into non-invasive physical therapy^[@ref3]^, pharmacotherapy^[@ref4]^, counseling assurance^[@ref5]^, and occlusal splint therapy^[@ref6]^. Minimally invasive arthrocentesis^[@ref7]^, acupuncture^[@ref8]^, and lasers^[@ref9]^ are among the invasive surgical intervention methods^[@ref10]^.

Occlusal splints are considered a simple, chair-side, and less invasive treatment. Occlusal splints are the favorable treatment of choice in our institute after medications. The clinical findings of occlusal splints for the treatment of both myofascial pain dysfunction (MPD) syndrome and disk displacement are controversial and they may act as a placebo rather than a specific therapeutic mechanism^[@ref11]^.

Regardless of the splint mode of action, many old and several recent clinical trials and systematic reviews have documented its therapeutic effectiveness in reducing pain intensity and improving masticatory function in patients with painful temporomandibular disorder (TMD)^[@ref12],[@ref13]^. However, most of the current literature did not demonstrate any beneficial effect in short-term^[@ref14]^ and long-term follow-up^[@ref15]^.

Among the causes of variability between the results, patients with TMJD cannot be considered a homogeneous group and will respond differently, with investigators relying on subjective symptoms reported by the patients. Moreover, studies can present with inadequate sample sizes, short follow-up periods, poor quality of the control group, and bias in data reporting. Proper evaluation of splint appliance therapy is achieved by applying long-term follow-ups, randomized controlled study designs, recruitment of a homogeneous population, and blinding in data extraction.

The investment in evidence-based medicine and its role in improving the acceptance of studies for publication, besides the natural progress of the disease, recent diagnostic measures, and improvement of communication between clinicians and patients means it is likely these account for changes in the old concepts that previously guided temporomandibular joint (TMJ) treatment.

This review was conducted to shed light on doubts about the therapeutic value of oral splints through a meta-analysis of data from different relevant randomized controlled trials (RCTs) and studies of different types of occlusal splints. Our purpose was to evaluate the effectiveness of splint therapy in ameliorating pain issues in patients with TMJD.

II. Materials and Methods
=========================

The recommendations from the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement were followed^[@ref16]^.

1. Eligibility criteria
-----------------------

### 1) Inclusion criteria

RCT studies that were conducted in humans over the past twenty years. Patients with TMJD that included myofascial pain with the source of pain being either muscular or from the joint, and patients with disk displacements with or without reduction. Studies that compared splints to non-invasive treatment (medications-biofeedback, counseling, and non-occluding splints). Patient diagnosis was either based on Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) or clinical examination.

### 2) Excluded from the study

Published studies older than twenty years, studies on animals, uncontrolled studies comparing different types of splints with each other, or studies with minimally invasive treatment modalities (low-level laser, arthrocentesis, acupuncture, and physiotherapy). If there were multiple comparisons within the same study, each comparison was included separately. Moreover, various intervals within the related research were recorded in each relevant subgroup.

2. Population
-------------

Patients with myofascial pain and/or disk displacement with or without reduction were included. Patients with arthritis or neuralgias were excluded.

3. Intervention
---------------

The study included all types of splints (stabilizing splint, Michigan splint, centric relation appliance, flat occlusal appliance, soft or hard splints, vinyl appliances, and positioning splints).

4. Control group
----------------

The patients in the control group underwent medical treatment, biofeedback, non-occluding splints, massages, behavioral therapy, cognitive, counseling, or no treatment.

5. Outcome
----------

### 1) Primary outcome

Pain intensity was estimated with any recognized, validated pain scale: visual analogue scale, numeric rating scale, characteristic pain intensity, and symptom severity index. Subgroup analyses were carried out for the outcomes based on the follow-up duration classified into one, two, three, six, and twelve months.

### 2) Secondary outcome

Maximum mouth opening (MMO) was evaluated by inter-incisal opening measured in millimeters.

6. Search methods for studies identification
--------------------------------------------

The search for studies in the English language was conducted up to August 2018. The following databases were searched individually from 1998 to the present: MEDLINE, Web of Science, EMBASE, and Egyptian Knowledge Bank. Manual searches, references from primary studies, and systematic reviews for relevant data were obtained. The search used a combination of controlled vocabulary: 'temporomandibular joint disorders'\[MeSH Terms\] OR 'temporomandibular'\[All Fields\], AND 'joint'\[All Fields\], AND 'disorders'\[All Fields\], OR 'temporomandibular joint disorders'\[All Fields\], OR ('temporomandibular'\[All Fields\] AND 'disorders'\[All Fields\]) OR 'temporomandibular disorders'\[All Fields\], OR 'mouth'\[MeSH Terms\] OR 'mouth'\[All Fields\] OR 'oral'\[All Fields\]) AND ('splints'\[MeSH Terms\] OR 'splints'\[All Fields\] OR 'splint'\[All Fields\]). 'temporomandibular joint'\[MeSH Terms\] OR ('temporomandibular'\[All Fields\] AND 'joint'\[All Fields\]) OR 'temporomandibular joint'\[All Fields\] OR 'TMJ'\[All Fields\], AND 'pain'\[MeSH Terms\] OR 'pain'\[All Fields\].

7. Data extraction and management
---------------------------------

Both continuous (mean, standard deviation) and dichotomous (event, control) studies were included in the analysis.

8. Assessment of study risk of bias
-----------------------------------

All included studies were evaluated with consent from the Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0^[@ref17]^. The risk of bias was assessed using Cochrane Collaboration's tool with response options of 'low risk', 'unclear risk', and 'high risk' for the following criteria: sequence generation, allocation concealment, blinding, incomplete outcome data, reporting bias, and other biases.

9. Measurements of the treatment effect
---------------------------------------

### 1) Pain intensity

Standardized mean difference (SMD) with 95% confidence interval (CI) and fixed effects were used for continuous outcomes. For dichotomous outcomes, the estimate of the effect was expressed as a risk ratio (RR) together with 95% CIs and random effects.

### 2) Maximum mouth opening

The mean difference (MD) with 95% CI and fixed effects was used for the assessment of the outcomes.

### 3) Assessment of heterogeneity

Chi-square testing for heterogeneity was performed, and the extent of the inconsistency of the treatment effects (I^2^) across the trials was measured. We considered heterogeneity substantial if I^2^ was greater than 30%, or if there was a low *P*-value (less than 0.10) in the chi-square test for heterogeneity. We used a fixed-effect meta-analysis for combining the data, but clinical heterogeneity random-effect was used in the subgroup analyses.

### 4) Assessment of reporting biases

Publication bias was appraised using the symmetry of the funnel plots. We visually assessed funnel plot asymmetry. When asymmetry was detected, investigations were performed using exploratory analyses.

### 5) Methodological quality assessment

Data synthesis and meta-analyses were performed according to the rules adopted by the Cochrane Collaboration reviewer's handbook^[@ref17]^. All statistical analyses were conducted using Review Manager software (RevMan 5.3).

III. Results
============

The initial search yielded a total of 2,418 titles: 1,763 from PubMed, 51 from EMBASE, 385 from the Cochrane Central library, 182 from the Web of Science, 5 from Egyptian Knowledge Bank (ClinicalKey), and 32 through manual searches.

After reviewing the abstracts, 1,377 studies were excluded from the analysis, and 1,041 were considered for further full-text screening. Finally, a total of 22 studies^[@ref14],[@ref15],[@ref18]-[@ref37]^ were included in this systematic review^[@ref38]^.([Fig. 1](#F1){ref-type="fig"})

1. Results and study characteristics
------------------------------------

### 1) Primary outcome (pain intensity) ([Fig. 2](#F2){ref-type="fig"})

#### (1) Short follow-up period: up to one month

[Table 1](#T1){ref-type="table"} reviews the summary of the included subgroup studies. Studies starting from the one week follow-up period up to one month included a total of eight studies with ten comparisons^[@ref14],[@ref18]-[@ref24]^, two of them comparing occlusal splints with medications^[@ref18],[@ref23]^, and two comparisons of soft and hard occlusal splints with a non-occluding palatal splint^[@ref19]^. Two studies compared occlusal splints versus exercise^[@ref14],[@ref20]^, two studies compared them with counseling^[@ref22],[@ref24]^, and the last two compared them with no treatment^[@ref18],[@ref21]^.

Control groups in four comparisons reported better pain reduction compared to splint therapy^[@ref14],[@ref19],[@ref20]^; however, the other six comparisons favored splint therapy^[@ref18],[@ref21]-[@ref24]^.

Total subgroup analysis of the eight identified studies with a total of 396 participants revealed non-significant overall effects on pain reduction (SMD --0.11, 95% CI --0.31 to 0.08, *P*=0.67, I^2^=0%).

#### (2) Short term evaluation: up to two months

Studies with a follow-up period greater than one month and up to two months were included. Subgroups included eight studies with nine comparisons^[@ref18]-[@ref22],[@ref25]-[@ref27]^. Three comparisons involved non-occluding palatal splints^[@ref19],[@ref25],[@ref26]^, three comparisons involved exercise^[@ref20],[@ref21],[@ref25]^, and one study compared occlusal splints versus counselling^[@ref22]^ with a single comparison for every medical treatment^[@ref18]^ and cognition^[@ref27]^.

In five comparisons, the control group exhibited better results than splints^[@ref18]-[@ref20],[@ref25],[@ref26]^, with four comparisons in favor of splints^[@ref18],[@ref19],[@ref22],[@ref27]^. The total subgroup analysis of the identified studies with a total of 385 participants revealed non-significant overall effects on pain reduction (SMD 0.18, 95% CI --0.02 to 0.38, *P*=0.08, I^2^=16%).

#### (3) Intermediate follow-up period: three months

Nine studies with thirteen comparisons at the three months' follow-up period were included^[@ref14],[@ref15],[@ref19],[@ref23],[@ref28]-[@ref32]^. One study compared occlusal splints with medications^[@ref23]^, two studies involved occlusal splints with a non-occluding palatal splint^[@ref19]^, and three studies compared occlusal splints with counselling^[@ref15],[@ref31]^. Two studies by Wahlund et al.^[@ref29],[@ref32]^ compared splints with relaxation, and two comparisons with self-care^[@ref30]^.

In twelve studies, the control group exhibited better results than the splints^[@ref14],[@ref15],[@ref19],[@ref23],[@ref28]-[@ref31]^, with one study in favor of splints^[@ref32]^.

Total subgroup analysis of the identified studies with a total of 704 participants revealed a significant overall effect on pain reduction in favor of the control (SMD 0.18, 95% CI 0.03-0.33, *P*=0.02, I^2^=0%).

#### (4) Long term evaluation

##### (i) Six months

Five studies at the six months' follow-up period^[@ref15],[@ref23],[@ref27],[@ref32],[@ref37]^ were included with one study comparing occlusal splints with medications^[@ref23]^. Two comparisons between splint and counselling^[@ref15],[@ref37]^ One study compared splints with relaxation^[@ref32]^, while the remaining study compared occlusal splints versus cognition^[@ref27]^.

All five studies in the control group showed better results than splints regarding pain reduction.

Total subgroup analysis of the identified studies with total of 213 participants revealed a significant overall effect on pain reduction in favor of the control (SMD 0.31, 95% CI 0.03-0.58, *P*=0.03, I^2^=0%).

##### (ii) One-year follow-up

Four studies with five comparisons at the one-year follow-up period^[@ref15],[@ref28],[@ref30],[@ref33]^ were included. One study compared occlusal splints with no treatment^[@ref28]^, two studies compared splints and counselling^[@ref15],[@ref33]^, and two comparisons of Truelove et al.^[@ref30]^ compared soft and hard splints with self-care.

In all five comparisons, the control group exhibited better results than splints regarding pain reduction.

Total subgroup analysis of the identified studies with total of 344 participants revealed a significant overall effect on pain reduction in favor of the control (SMD 0.23, 95% CI 0.01-0.44, *P*=0.04, I^2^=0%).

#### (5) Total analysis

The five included subgroups reveal moderate heterogeneity between them (I^2^=53.9%). However, no heterogeneity between the individual studies (I^2^=0%) was observed. The overall effect of the meta-analysis with a total of 2,042 participants revealed a significant difference between the control and splint therapy in favor of the control group (SMD 0.14, 95% CI 0.05-0.23, *P*=0.002, I^2^=0%).

#### (6) Dichotomous studies ([Fig. 3](#F3){ref-type="fig"})

Five studies were included^[@ref25],[@ref26],[@ref28],[@ref33],[@ref34]^. Two studies compared manual mobilization and active exercises^[@ref25],[@ref33]^, two studies compared splints with a palatal non-occluded splint^[@ref26],[@ref34]^, and one study compared splints with no treatment^[@ref28]^.

Total analysis of the identified studies with a total of 164 participants revealed no significant overall effects of splint therapy on pain reduction (RR 1.12, 95% CI 0.84-1.50, *P*=0.45, I^2^=0%).

### 2) Secondary outcome

#### (1) Maximum mouth opening

##### (i) Short-term evaluation

[Table 2](#T2){ref-type="table"} presents a summary of the included subgroup studies. Included studies involved a follow-up period up to three months. Subgroups included five studies with nine comparisons^[@ref18],[@ref24],[@ref25],[@ref35],[@ref36]^. In five comparisons, the splint group exhibited better results than the non-splint group^[@ref18],[@ref25],[@ref36]^ and four comparisons were in favor of the control^[@ref18],[@ref24],[@ref35]^.

Total subgroup analysis of the identified studies with a total of 386 participants revealed non-significant overall effects on the improvement in mouth opening (MD --0.87, 95% CI --2.29 to 0.55, *P*=0.23, I^2^=0%).

##### (ii) Long-term evaluation

Included studies involved a follow-up period up to one year. Subgroups included four studies with eight comparisons^[@ref28],[@ref29],[@ref31],[@ref32]^. In two comparisons, the splint group exhibited better results than then control^[@ref30]^, and six comparisons were in favor of the control group^[@ref28],[@ref29],[@ref32]^.

Total subgroup analysis of the identified studies with a total of 398 participants revealed non-significant overall effects on the improvement of mouth opening (MD --0.62, 95% CI --1.96 to 0.72, *P*=0.37; I^2^=0%).

Total analysis of the identified studies with a total of 784 participants revealed no significant overall effects of splint therapy on MMO (MD --0.74, 95% CI --1.71 to 0.24, *P*=0.14, I^2^=0%).([Fig. 4](#F4){ref-type="fig"})

### 3) Methodological quality assessment

#### (1) Risk of bias across all the included studies

Nine studies had a high risk for selection bias (random sequence generation) (41%), eleven studies were at high risk of selection bias (allocation concealment) (50%), five studies had performance bias (23%), eight studies exhibited detection bias (36%), three studies had attrition bias (14%), and finally two studies exhibited reporting bias (1%).

The funnel plots declared no publication bias for the two primary outcomes, continuous and dichotomous, in both short and long-term follow-up periods ([Fig. 5](#F5){ref-type="fig"}) and also no publication bias for the secondary outcome (MMO).

IV. Discussion
==============

Systematic reviews are a critical assessment tool in evidence-based decision-making. This study was assigned to PRISMA^[@ref16]^ statements for systematic reviews. Well-structured PICO (Problem Intervention-Comparison-Outcome) questions with clearly outlined inclusion and exclusion criteria were also included. A publication bias analysis was performed for every outcome using funnel plots.

Pain is considered the most common reason for medical consultation. Therefore, it was selected as the primary outcome of this review. However, restoring the normal range of mouth opening, and subsequently, normal masticatory and jaw function was the secondary outcome examined.

We investigated the effects of splint therapy as a conservative TMD treatment modality in reducing pain intensity and improving mouth opening through the analysis of twenty-two included studies.

There is no gold standard control to compare the different types of splints. Therefore, all the splints included in the current review were compared with no treatment or behavioral therapy.

Over-estimation of the effect of treatment resulted from an improper means of randomization, neglecting concealment of treatment allocation, not adequately blinded assessments, short follow-ups, or lacking of study power due to small sample sizes being the most serious problems.

Although several studies investigated splint therapy, the results remain controversial. Methodological differences among the studies are evident, and a comparison of the results is often difficult due to heterogeneity. The clinical relevance of these findings shows a need for more well-designed RCTs.

Studies that were older than twenty years were excluded due to the introduction of RDC/TMD classification which decreases diagnostic pitfalls and improves population selection. The use of recent materials and continuous changes in splint design all may confound the results associated with the classification's effectiveness.

In this systematic review, we tried to minimize bias across the studies and obtain maximal homogeneity among the subgroups by using appropriate eligibility criteria and selecting only studies with the control group receiving no treatment or palliative treatment. Subsequently, meta-regression analysis was not required.

In the current review, subgroups were selected according to the recommendation of Pficer et al.^[@ref39]^ who studied confounding factors with meta-regression analysis and found that that duration of treatment is one of the parameters that could affect the outcome of using oral splints. He reported that investigators should pay attention not only to the short-term but also long-term therapeutic effects in their studies.

Continuous outcome data was obtained using SMD, 95% CI, and applying inverse variance with a fixed effect for accurate analysis. For dichotomous pain intensity data, we used relative risk and random effects because of the low number of included studies and heterogeneity.

For secondary outcomes based on continuous data, we used MD because of using the same scale in measurements and 95% CI. Inverse variance and fixed effects were applied to achieve sensitive analysis.

In short-term follow-ups, oral splints exhibited no significant effect on pain reduction. However, in long-term follow-ups, behavioral therapy was associated with significant pain reduction.

These findings do not mean that behavioral therapy is better than oral splints, but that the effect of splint therapy was abolished or equal to no treatment after an extended period of time.

The findings of the conducted review follow the individual studies^[@ref18]-[@ref20],[@ref24],[@ref26]-[@ref28],[@ref30],[@ref33],[@ref40]^ that did not observe any difference between splint therapy and placebos.

Most of the reviews that compared splints with lasers, arthrocentesis, acupuncture, or physiotherapy resulted in fake estimations because such comparisons depend on the power of the comparator and do not provide a clue about the actual estimation.

There are several articles that included studies comparing splints with behavioral treatment, pharmacologic treatment, arthroscopy, surgical intervention, or no treatment^[@ref41]^.

This review showed that there is no evidence to suggest that splint therapy is beneficial for pain reduction measured with different scales or even effective in reducing symptoms in patients with myofascial pain when compared with placebo or no treatment. These findings are in agreement with the systematic review by Al-Ani et al.^[@ref42]^.

There was no evaluation of each splint type separately, and the populations were mixed including disk displacement with myofascial pain participants. Non-occluding splints were considered as controls which may have some effects through the repositioning of the tongue and patient awareness issues.

We recommend an evaluation of each type of splint separately and subgroup analysis separating cases of myofascial pain from cases of disk displacement.

V. Conclusion
=============

Based on the limitations of the included studies in this systematic review due to considerable bias in selection, concealment, and blinding, the present outcome suggests that oral splints are not effective for either the reduction of pain intensity or improvement in MMO compared to control groups in patients with TMJD.

Further assessment with a higher level of evidence including studies with proper selection randomization, concealment, calculated sample size, and blinding for better estimation of the effectiveness of splint therapy in patients with TMJD are needed.

Apparent improvements observed in most of the studies on oral splints are due to the placebo effect or the natural remission of symptoms.

Oral splints can be used only as an adjunct to other non or minimally invasive treatments for TMJD management. Furthermore, oral splints could be helpful in blocking bad habits and bruxism in order to inhibit dental damage potentially induced by that disorder.

Our results confirmed that the effect of splint therapy for pain reduction in short-term durations is better than that seen in control groups, but that results becomes insignificant with fading effects in long-term studies.
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###### 

Summary of the included studies

  Study (first author)          Publication year   Diagnostic mean   Diagnosis   Pain measurement tool   Study splint type   Control        No. of participants   Follow-up period
  ----------------------------- ------------------ ----------------- ----------- ----------------------- ------------------- -------------- --------------------- ------------------
  Minakuchi^[@ref18]^           2001               Clinical          DD          VAS                     OS                  NSAID          48                    4 wk
  Minakuchi^[@ref18]^           2001               Clinical          DD          VAS                     OS                  No treatment   46                    4 wk
  Alencar Jr^[@ref19]^          2009               Clinical          MPD         SSI                     Soft splint         NOS            28                    1 mo
  Alencar Jr^[@ref19]^          2009               Clinical          MPD         SSI                     Hard splint         NOS            28                    1 mo
  Haketa^[@ref20]^              2010               Clinical          DD          VAS                     OS                  Exercise       44                    4 wk
  Niemelä^[@ref24]^             2012               RDC/TMD           MPD         VAS                     SS                  Counseling     76                    1 mo
  Giannakopoulos^[@ref21]^      2016               RDC/TMD           MPD         NRS                     Soft splint         No treatment   24                    2 wk
  Hasanoglu Erbasar^[@ref22]^   2017               RDC/TMD           MPD         VAS                     NTI-tss             Counseling     40                    3 wk
  Hosgor^[@ref23]^              2017               RDC/TMD           DD          VAS                     SS                  NSAID          20                    1 mo
  Giannakopoulos^[@ref14]^      2018               RDC/TMD           MPD         NRS                     Michigan splint     Exercise       42                    2 wk
  Raphael^[@ref26]^             2001               RDC/TMD           MPD         PI                      Hard splint         NOS            63                    6 wk
  Carmeli^[@ref25]^             2001               Clinical          DD          PI                      Soft splint         Exercise       36                    5 wk
  Minakuchi^[@ref18]^           2001               Clinical          DD          VAS                     OS                  NSAID          48                    2 mo
  Alencar Jr^[@ref19]^          2009               Clinical          MPD         SSI                     Soft splint         NOS            28                    2 mo
  Alencar Jr^[@ref19]^          2009               Clinical          MPD         SSI                     Hard splint         NOS            28                    2 mo
  Shedden Mora^[@ref27]^        2013               RDC/TMD           DD          VAS                     OS                  Cognition      56                    2 mo
  Giannakopoulos^[@ref21]^      2016               RDC/TMD           MPD         NRS                     Soft splint         No treatment   24                    6 wk
  Hasanoglu Erbasar^[@ref22]^   2017               RDC/TMD           MPD         VAS                     NTI-tss             Counseling     40                    6 wk
  Haketa^[@ref20]^              2010               Clinical          DD          VAS                     OS                  Exercise       44                    8 wk
  Wahlund^[@ref29]^             2003               RDC/TMD           MPD         PI                      SS                  BI             81                    3 mo
  Wahlund^[@ref29]^             2003               RDC/TMD           MPD         PI                      SS                  Relaxation     81                    3 mo
  Truelove^[@ref30]^            2006               RDC/TMD           MPD         PI                      Hard splint         Self-care      108                   3 mo
  Truelove^[@ref30]^            2006               RDC/TMD           MPD         PI                      Soft splint         Self-care      110                   3 mo
  Wassell^[@ref28]^             2006               Clinical          MPD         VAS                     SS                  NOS            72                    3 mo
  Alencar Jr^[@ref19]^          2009               Clinical          MPD         SSI                     Soft splint         NOS            28                    3 mo
  Alencar Jr^[@ref19]^          2009               Clinical          MPD         SSI                     Hard splint         NOS            28                    3 mo
  Wahlund^[@ref32]^             2015               RDC/TMD           MPD         NRS                     SS                  Relaxation     57                    3 mo
  Conti^[@ref31]^               2015               RDC/TMD           DD          PI                      ARS                 Counseling     21                    3 mo
  Conti^[@ref31]^               2015               RDC/TMD           DD          PI                      NTI-tss             Counseling     21                    3 mo
  Hosgor^[@ref23]^              2017               RDC/TMD           DD          VAS                     SS                  NSAID          20                    3 mo
  Giannakopoulos^[@ref14]^      2018               RDC/TMD           MPD         NRS                     SS                  Exercise       42                    3 mo
  Kokkola^[@ref15]^             2018               RDC/TMD           MPD         OHIP                    SS                  Counseling     39                    3 mo
  Shedden Mora^[@ref27]^        2013               RDC/TMD           DD          VAS                     SS                  Cognition      56                    6 mo
  Katyayan^[@ref37]^            2014               RDC/TMD           MPD         VAS                     SS                  Counseling     80                    6 mo
  Wahlund^[@ref32]^             2015               RDC/TMD           MPD         NRS                     SS                  Relaxation     22                    6 mo
  Hosgor^[@ref23]^              2017               RDC/TMD           DD          VAS                     SS                  NSAID          20                    6 mo
  Kokkola^[@ref15]^             2018               RDC/TMD           MPD         OHIP                    SS                  Counseling     35                    6 mo
  Truelove^[@ref30]^            2006               RDC/TMD           MPD         PI                      Hard splint         Self-care      113                   1 yr
  Truelove^[@ref30]^            2006               RDC/TMD           MPD         PI                      Soft splint         Self-care      103                   1 yr
  Qvintus^[@ref33]^             2015               RDC/TMD           MPD         VAS                     SS                  Counseling     46                    1 yr
  Wassell^[@ref28]^             2006               Clinical          MPD         VAS                     SS                  No treatment   39                    1 yr
  Kokkola^[@ref15]^             2018               RDC/TMD           MPD         OHIP                    SS                  Counseling     43                    1 yr
  Ekberg^[@ref34]^              2004               Clinical          MPD         VAS                     SS                  NOS            40                    1 yr

(DD: disk displacement, VAS: visual analogue scale, OS: occlusal splint, NSAID: nonsteroidal antiinflammatory drugs, MPD: myofascial pain dysfunction, SSI: symptom severity index, NOS: non-occluding splint, RDC/TMD: research diagnostic criteria of temporomandibular dysfunction, SS: stabilizing splint, NRS: numeric rating scale, NTI-tss: nociceptive trigeminal inhibition-tension suppression system, PI: pain intensity, BI: brief information, ARS: anterior reposition splint, OHIP: oral health impact profile)

###### 

Summary of the included studies of short- and long-term maximum mouth opening (MMO) subgroup analysis

  Study (first author)   Publication year   Diagnostic mean   Diagnosis   Pain measurement tool   Study splint type   Control         No. of participants
  ---------------------- ------------------ ----------------- ----------- ----------------------- ------------------- --------------- ---------------------
  Carmeli^[@ref25]^      2001               Clinical          DD          MM                      Soft splint         Exercise        36
  Minakuchi^[@ref18]^    2001               Clinical          DD          MM                      Flat OS             NSAID           50
  Minakuchi^[@ref18]^    2001               Clinical          DD          MM                      Flat OS             No treatment    46
  Niemelä^[@ref24]^      2012               RDC/TMD           MPD         MM                      SS                  Counseling      76
  Gomes^[@ref35]^        2014               Clinical          MPD         MM                      OS                  No treatment    28
  Gomes^[@ref35]^        2014               Clinical          MPD         MM                      OS                  Massage         28
  Wassell^[@ref28]^      2006               AAOFP             MPD         MM                      SS                  NOS             39
  Wassell^[@ref28]^      2006               AAOFP             MPD         MM                      SS                  NOS             72
  Wahlund^[@ref29]^      2003               RDC/TMD           MPD         MM                      OS                  BI+relaxation   83
  Wahlund^[@ref29]^      2003               RDC/TMD           MPD         MM                      SS                  BI+relaxation   83
  Wahlund^[@ref32]^      2015               RDC/TMD           MPD         MM                      SS                  Relaxation      57
  Conti^[@ref31]^        2015               Clinical          DD          MM                      SS                  Relaxation      22
  Conti^[@ref31]^        2015               Clinical          DD          MM                      ARS                 Counseling      21
  Conti^[@ref31]^        2015               Clinical          DD          MM                      NTI-tss             Counseling      21

(DD: disk displacement, MM: inter-incisal opening in millimeters, OS: occlusal splint, NSAID: nonsteroidal antiinflammatory drugs, RDC/TMD: research diagnostic criteria of temporomandibular dysfunction, MPD: myofascial pain dysfunction, SS: stabilizing splint, BI: brief information, NTI-tss: nociceptive trigeminal inhibition-tension suppression system, AAOFP: American Academy of Orofacial Pain, ARS: anterior reposition splint, NOS: non-occluding splint)
